Warner Chilcott US LLC

FDA Regulatory Profile

Warner Chilcott US LLC appears in FDA public data with 1 recall, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-822-2013, Class II) was initiated on May 17, 2013.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
1
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-822-2013Class IIEnablex (darifenacin) Extended Release Tablet, 15 mg per tablet. Physician Sample 7 Tablets bottle,May 17, 2013